HLA class II associated with outcomes of hepatitis B and C infections. - Wikidata - awgldk - TriplyDB

HLA class II associated with outcomes of hepatitis B and C infections.

HLA class II associated with outcomes of hepatitis B and C infections.

http://www.wikidata.org/entity/Q42582521

about

Hepatitis B virus infection and alcohol consumption Virus-related liver cirrhosis: molecular basis and therapeutic options.Genetic variants in human leukocyte antigen-DP influence both hepatitis C virus persistence and hepatitis C virus F protein generation in the Chinese Han population.Genetic variants in antigen presentation-related genes influence susceptibility to hepatitis C virus and viral clearance: a case control study.Role of viruses and other microbes in the pathogenesis of type 1 diabetes.Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus A method for reporting and classifying acute infectious diseases in a prospective study of young children: TEDDY Human Leukocyte Antigen Class II Alleles Are Associated with Hepatitis C Virus Natural Susceptibility in the Chinese Population.Genetic Contribution of MHC Class II Genes in Susceptibility to West Nile Virus Infection.A novel polymorphism near HLA class II region is associated with spontaneous clearance of HCV and response to interferon treatment in Chinese patients.Association of human leukocyte antigen haplotypes with clearance and persistence of hepatitis B virus infection in northeastern China.Spontaneous Elimination of Hepatitis C Virus Infection.Association between human leucocyte antigen-DO polymorphisms and interferon/ribavirin treatment response in hepatitis C virus type 1 infection in Chinese population: a prospective study.

P2860

Q33599503-380489BB-A5AC-4EFE-83B5-35CD358BDE4A Q33718267-9B47AA8C-2E15-4B38-8D98-6EEE9E30B5DE Q33907605-9677B803-CECE-4B98-A9AA-39D66903C94E Q34787490-6CA1EC46-E2FD-403C-A138-45E3BB0FA3E0 Q35115373-1DC93E7F-D06D-4B0A-A38B-7AC0589EE924 Q35158581-6967AF4F-2FFF-4FCA-A136-63C8E9C4F72E Q35225752-94908EFA-0819-47F0-9B34-499E33C85CC7 Q36088382-59A7599B-5874-49CA-84E9-D3D6E044E030 Q36182414-6CFA591B-2A49-4FD4-94E1-F686832622B3 Q40884603-5B230F39-3A26-4934-8489-37DAEC157D60 Q41542632-2B0E5679-7C56-49A6-B00B-BEB8E2C69F4A Q45324431-08B42718-A48B-4FFC-80E9-5D4971A64F00 Q52589250-B66A757F-F4FA-4C4D-956C-821E764BEF58

P2860

HLA class II associated with outcomes of hepatitis B and C infections.

http://www.wikidata.org/entity/Q42582521

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

HLA class II associated with outcomes of hepatitis B and C infections.

@en

HLA class II associated with outcomes of hepatitis B and C infections.

@nl

type

label

HLA class II associated with outcomes of hepatitis B and C infections.

@en

HLA class II associated with outcomes of hepatitis B and C infections.

@nl

prefLabel

HLA class II associated with outcomes of hepatitis B and C infections.

@en

HLA class II associated with outcomes of hepatitis B and C infections.

@nl

P1433

Q42582521-EE9ECF5C-94F4-4EE1-8B2B-EA20C9A44371

P1476

Q42582521-506FB28A-718C-4A7A-A86E-CEE26139D0F1

P2093

Q42582521-03E5FE41-7259-4A82-BCC3-62414212DC2B

Q42582521-04018B0C-90CB-481A-BA97-C82A73FFF66E

P2860

Q42582521-04C144CC-1525-4AE0-A9A6-5B7628C82E0B

Q42582521-0684BDB3-A1F8-41F0-82BC-DDC6914A21AD

Q42582521-0D258B1B-C240-41A7-B12C-26DAA0A0949E

Q42582521-1205984D-E23B-4CD2-81B1-E0B6EEB1A8CC

Q42582521-22D8887F-275B-49FD-863E-AB338F88CD2B

Q42582521-24F0F075-3BE9-4A0F-809D-E9D88F719A7C

Q42582521-288FE514-4728-42F0-A760-6B6B473416A5

Q42582521-2F12BFBD-AB23-4BDF-B1E8-782B56A7F60D

Q42582521-49AEE71D-56EF-4DEB-A4AA-0C273ECF955F

Q42582521-55A261A9-E7AE-4F02-9479-389A5259CE35

P304

Q42582521-7E02DBB4-A956-4E83-930B-2D6E19D607DD

P31

Q42582521-2c5c9ea0-7b4e-4fea-8919-9f4548fea648

Q42582521-56536A9A-C5E4-48A9-9A21-F47900665583

P356

Q42582521-441177BB-8581-483E-A0BA-EDE3D204E00D

P407

Q42582521-13EFB06C-CD00-4CD7-9479-C3234BB59273

P433

Q42582521-7373F93A-F1CF-49C9-91E2-3551643CE660

P478

Q42582521-4F362D74-08C8-48C6-ADB2-79B53F195912

P577

Q42582521-2005DC4B-DAC4-4B74-BAA6-5B9BFFA4DCC2

P698

Q42582521-FA74ADB9-A051-4B0C-A158-FDD9563D2225

P932

Q42582521-7145270B-DC75-4A17-88C5-D6412419C420

P356

WJG.V19.I33.5395

P1433

World Journal of Gastroenterology

P1476

HLA class II associated with outcomes of hepatitis B and C infections.

@en

P2093

Akihiro Tamori

http://www.w3.org/2001/XMLSchema#string

Norifumi Kawada

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

A map of human genome variation from population-scale sequencing

Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: a meta-analysis

Genomewide association studies and assessment of the risk of disease

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

A comparative review of HLA associations with hepatitis B and C viral infections across global populations

Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean

A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region

GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers

Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers

P304

5395-5401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V19.I33.5395

http://www.w3.org/2001/XMLSchema#string

P407

P433

33

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24023482

http://www.w3.org/2001/XMLSchema#string

P932

3761092

http://www.w3.org/2001/XMLSchema#string